Ligand validation:3SDF

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3SDF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3SDF_NAG_A_1	10%	50%	0.29	0.801	0.53	1.37	-	2	3	0	93%	0.9333
4OQO_NAG_A_702	64%	42%	0.118	0.916	0.65	1.58	-	3	0	0	100%	0.9333
7FDW_NAG_B_701	54%	43%	0.122	0.885	0.83	1.35	-	2	0	0	100%	0.9333
5CRY_NAG_B_704	50%	26%	0.151	0.9	0.71	2.23	-	4	0	0	100%	0.9333
5HBC_NAG_B_704	49%	26%	0.151	0.899	0.71	2.23	-	4	0	0	100%	0.9333
7EVQ_NAG_B_701	40%	74%	0.172	0.881	0.48	0.52	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.